
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage, for any covered stock.
TapClick below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
TapClick below to see what's inside, then upgrade to unlock for XYL and 80,000+ other tickers.
See price against where its own fundamentals say it should trade. The shaded gap is the discount or premium, across five valuation lenses.
TapClick below to see what's inside, then upgrade to unlock for XYL and 80,000+ other tickers.
The latest quarter of all 8 metrics Xylem Inc. reports, from its segment revenue to its operating figures, each with its change from the quarter before and from a year earlier, and its history back to Dec 2018.
TapClick below to see what's inside, then upgrade to unlock it for XYL and every other company we cover.
See exactly how XYL's revenue becomes profit: a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for XYL and 80,000+ other tickers.
Xylem Inc., together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions for utility, industrial, and residential and commercial building services settings worldwide. It operates through Water Infrastructure; Applied Water; Measurement and Control Solutions; and Water Solutions and Services segments. The company offers water, wastewater, and storm water pumps and controls and systems; filtration, disinfection, and biological treatment equipment under the Flygt, Ionpure, Leopold, Neptune Benson, Sanitare, Wallace & Tiernan, and Wedeco…

Xylem raised its 2026 adjusted EPS range on July 28, 2026, then cut it on October 27 to a midpoint below where it stood before the raise. XYL shareholders who lost money have legal rights, and an investigation into potential securities law violations is reviewing those losses.

Xylem has sharply underperformed, falling over 30% YTD and missing Q3 2026 revenue and EPS expectations. Management cut FY26 guidance, projecting revenue at $8.95B and EPS at $5.40–$5.45, citing project delays and weak sales in most segments. Despite near-term headwinds, XYL's backlog grew 13% YoY to $5.5B, and orders remain strong, especially in Applied Water and Measurement & Control Solutions.

Xylem's third-quarter revenue came in roughly $80 million below Wall Street's estimate, and adjusted EPS fell short of consensus. An investigation into potential securities law violations is reviewing losses suffered by XYL shareholders.

Xylem's Q3 earnings miss estimates as metering pressures and project timing weighed on sales, prompting it to lower its 2026 revenue and EPS outlook.

Xylem Inc. (XYL) Q3 2026 Earnings Call Transcript